544312 — Hamps Bio Income Statement
0.000.00%
Last trade - 00:00- IN₹187.31m
- IN₹216.98m
- IN₹66.69m
Annual income statement for Hamps Bio, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38.2 | 53.4 | 55.8 | 64.8 | 66.7 |
| Cost of Revenue | |||||
| Gross Profit | 19.1 | 31.4 | 37.8 | 47.7 | 46.7 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 39.5 | 50.5 | 50.5 | 57 | 62.8 |
| Operating Profit | -1.3 | 2.9 | 5.28 | 7.74 | 3.92 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.22 | 1.05 | 3.57 | 6.5 | 4.04 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.24 | 1.22 | 3.59 | 5.01 | 2.98 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.24 | 1.22 | 3.59 | 5.01 | 2.98 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.24 | 1.22 | 3.59 | 5.01 | 2.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.513 | 0.279 | 0.824 | 1.15 | 0.68 |